{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T06:41:06Z","timestamp":1791096066307,"version":"4.1.0"},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Modern Rheumatology"],"published-print":{"date-parts":[[2004,11]]},"DOI":"10.3109\/s10165-004-0325-2","type":"journal-article","created":{"date-parts":[[2014,1,2]],"date-time":"2014-01-02T14:53:15Z","timestamp":1388674395000},"page":"367-375","source":"Crossref","is-referenced-by-count":35,"title":["Anticyclic citrullinated peptide antibodies in patients with mixed connective tissue disease"],"prefix":"10.1093","volume":"14","author":[{"given":"Yoshinari","family":"Takasaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenjiro","family":"Yamanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiho","family":"Takasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masakazu","family":"Matsushita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirofumi","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masuyuki","family":"Nawata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Matsudaira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keigo","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiko","family":"Kaneda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2014,1,2]]},"reference":[{"key":"CIT0001","first-page":"148","volume":"52","author":"Sharp GC","year":"1972","journal-title":"Mixed connective tissue disease\u2014an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am J Med"},{"key":"CIT0003","doi-asserted-by":"crossref","first-page":"464","DOI":"10.4049\/jimmunol.96.3.464","volume":"96","author":"Tan EM","year":"1966","journal-title":"J Immunol"},{"key":"CIT0004","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1148\/120.2.269","volume":"120","author":"Silver TM","year":"1976","journal-title":"Radiology"},{"key":"CIT0005","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1259\/0007-1285-50-597-620","volume":"50","author":"O'Connell DJ","year":"1977","journal-title":"Br J Radiol"},{"key":"CIT0006","first-page":"613","volume":"124","author":"Udoff EJ","year":"1977","journal-title":"Radi-ology"},{"key":"CIT0007","first-page":"442","volume":"36","author":"Grennan DM","year":"1977","journal-title":"Frequency and clinical significance of antibodies to ribonucleoprotein in SLE and other connective tissue disease subgroups. Ann Rheum Dis"},{"key":"CIT0008","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/art.1780210502","volume":"21","author":"Halla JT","year":"1978","journal-title":"Arthritis Rheum"},{"key":"CIT0009","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/00005792-198007000-00001","volume":"59","author":"Nimelstein SH","year":"1980","journal-title":"Medicine"},{"key":"CIT0010","first-page":"155","volume":"43","author":"Schellekens GA","year":"2000","journal-title":"The diagnostic properties of rheu-matoid arthritis antibodies recognizing a cyclic citrullinated pep-tide. Arthritis Rheum"},{"key":"CIT0011","first-page":"1831","volume":"43","author":"Kroot EJ","year":"2000","journal-title":"The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheu-matoid arthritis. Arthritis Rheum"},{"key":"CIT0012","first-page":"383","volume":"60","author":"Van Venrooij WJ","year":"2002","journal-title":"Anticitrullinated protein\/ peptide antibody annd its role in the diagnosis and prognosis of early rheumatoiud arthritis. Neth J Med"},{"key":"CIT0013","first-page":"2741","volume":"48","author":"Rantapaa-Dahlqvist S","year":"2003","journal-title":"Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum"},{"key":"CIT0014","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1080\/03009740310003677","volume":"32","author":"Suzuki K","year":"2003","journal-title":"Scand J Ftheumatol"},{"key":"CIT0015","first-page":"263","volume":"1","author":"Kasukawa R","year":"1988","journal-title":"Miyawaki S. Mixed connective tissue disease: preliminary diagnostic criteria. Jpn J Ftheumatol"},{"key":"CIT0016","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/art.1780251101","volume":"25","author":"Tan EM","year":"1982","journal-title":"Arthritis Rheum"},{"key":"CIT0017","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/art.1780230510","volume":"23","author":"Subcommittee for Scleroderma Criteria of the American Rheuma-tism Association Diagnostic and Therapeutic Criteria Committee","year":"1980","journal-title":"Arthritis Rheum"},{"key":"CIT0018","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","volume":"31","author":"Arnett FC","year":"1988","journal-title":"Arthritis Rheum"},{"key":"CIT0019","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/00005792-197707000-00001","volume":"56","author":"Bohan A","year":"1977","journal-title":"Medicine (Baltimore)"},{"key":"CIT0020","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1002\/art.1780360309","volume":"36","author":"Vitali C","year":"1993","journal-title":"Arthritis Rheum"},{"key":"CIT0021","first-page":"1899","volume":"154","author":"Takasaki Y","year":"1981","journal-title":"Tan EM. A nuclear antigen associated with cell proliferation and blast transformation: its distribution in syn-chronized cells. J Exp Med"},{"key":"CIT0022","first-page":"302","volume":"23","author":"Nienhuis RLF","year":"1964","journal-title":"A new serum factor in patients with rheumatoid arthritis, the antiperinuclear factor. Ann Rheum Dis"},{"key":"CIT0023","first-page":"97","author":"Young BJJ","year":"1979","journal-title":"Anti-keratin antibodies in rheumatoid arthritis. BMJ"},{"key":"CIT0024","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1136\/ard.52.10.749","volume":"52","author":"Girbal E","year":"1993","journal-title":"specific for rheumatoid arthritis. Ann Rheum Dis"},{"key":"CIT0025","first-page":"1387","volume":"92","author":"Simon M","year":"1993","journal-title":"The cytokeratin filament-aggregating protein filaggrin is the target of the so-called \"antikeratin antibodies,\" autoantibodies specific for rheumatoid arthritis. J Clin Invest"},{"key":"CIT0026","first-page":"2672","volume":"95","author":"Sebbag M","year":"1995","journal-title":"The antiperinuclear factor and the so-called antikeratin antibodies are the same rheumatoid arthritis-specific autoantibodies. J Chin Invest"},{"key":"CIT0027","first-page":"42","volume":"58","author":"Vincent C","year":"1999","journal-title":"Anti-perinuclear factor compared with the so called \"antikeratin\" antibodies and antibodies to human epidermis filaggrin, in the diagnosis of arthritides. Ann Rheum Dis"},{"key":"CIT0028","first-page":"544","volume":"119","author":"Masson-Bessi\u00e8re C","year":"2000","journal-title":"In the rheumatoid pannus, anti-filaggrin autoantibodies are produced by local plasma cells and constitute a higher proportion of IgG than in synovial fluid and serum. Clin Exp Immunol"},{"key":"CIT0030","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1136\/ard.41.2.141","volume":"41","author":"Armstrong RD","year":"1982","journal-title":"Ann Rheum Dis"},{"key":"CIT0031","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1136\/ard.61.7.608","volume":"61","author":"Avcin T","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"CIT0032","first-page":"1451","volume":"30","author":"Zeng X","year":"2003","journal-title":"J Ftheumatol"}],"container-title":["Modern Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.3109\/s10165-004-0325-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,9]],"date-time":"2023-07-09T11:51:22Z","timestamp":1688903482000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/mr\/article\/14\/5\/367-375\/6313658"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,11]]},"references-count":30,"aliases":["10.1007\/s10165-004-0325-2"],"journal-issue":{"issue":"5","published-online":{"date-parts":[[2014,1,2]]},"published-print":{"date-parts":[[2004,11]]}},"alternative-id":["10.3109\/s10165-004-0325-2"],"URL":"https:\/\/doi.org\/10.3109\/s10165-004-0325-2","relation":{},"ISSN":["1439-7595","1439-7609"],"issn-type":[{"value":"1439-7595","type":"print"},{"value":"1439-7609","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,11]]}}}